NOVEL DRUGS AND DEVICES FOR IOP LOWERING

Chairpersons:

Dr. Carol Toris, University of Nebraska Medical Center, USA

Dr. Xavier Gasull, Universitat de Barcelona, Spain

 

Confirmed speakers:

Dr. Herbert Reitsamer, Paracelsus Medical University of Salzburg, Austria

Clinical studies of new glaucoma drainage devices

Dr. Janet Serle, Mount Sinai School of Medicine, USA

Effects of Investigational Compounds On Intraocular Pressure & Mechanism of IOP Reduction in Monkey Eyes

Dr. Carol Toris, University of Nebraska Medical Center, USA

Quantitative Differences Among Novel Glaucoma Devices in a Human Perfusion Model

Dr. Fernando Huete-Toral, Universidad Complutense de Madrid, Spain

Melatonin And Its Analogue 5-Mca-Nat Potentiate The Ocular Hypotensive Effect Mediated By Adrenergic Receptors: Significance For Glaucoma Treatment

Dr. Dan Stamer, Duke University, USA

Unique Response Profile of TM Cells to the novel SEGRA, GW870086X

17 December 2012